To hear about similar clinical trials, please enter your email below
Trial Title:
Molecular and Cellular Analysis of Breast Cancer
NCT ID:
NCT02243397
Condition:
Breast - Female
Breast - Male
Study type:
Observational
Overall status:
Suspended
Study design:
Time perspective:
Prospective
Summary:
The purpose of the study is to investigate the different types and subtypes of cells
found in breast tumors. The investigators will do this using a variety of molecular
analysis tools that may allow for improved tests. The different types of cells in breast
cancer impacts the way individuals respond to various treatments.
Criteria for eligibility:
Study pop:
breast cancer patients at Stanford Cancer Center
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Histologically proven diagnosis of breast cancer or a carcinoma of unknown primary
consistent with the presentation of a primary breast malignancy.
2. 18 years of age or older.
3. Ability to understand and the willingness to sign a written informed consent do
Exclusion Criteria:
- None
Gender:
Female
Minimum age:
18 Minutes
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Stanford University Cancer Institute
Address:
City:
Stanford
Zip:
94305
Country:
United States
Start date:
September 2014
Completion date:
September 2024
Lead sponsor:
Agency:
Stanford University
Agency class:
Other
Source:
Stanford University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT02243397
